Advanced Search

Oncology & Hematology Coding Alert

You Be the Coder:

How to Code Weekly Injection of Darbepoetin Alfa

Published on Tue Jun 19, 2018

Question: A patient who is on chemotherapy treatment for lymphoma, presents for a weekly injection of darbepoetin alfa. The patient was documented to receive 500 mcg of Aranesp subcutaneously. How can we report this service? New Jersey Subscriber Answer: From the description provided, it is evident that the patient reports for darbepoetin alfa injection. Darbepoetin alfa (Aranesp®) is an erythrocyte [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All